Healthcare Global Enterprises Limited (NSE:HCG) — Market Cap & Net Worth
Market Cap & Net Worth: Healthcare Global Enterprises Limited (HCG)
Healthcare Global Enterprises Limited (NSE:HCG) has a market capitalization of $873.06 Million (Rs80.73 Billion) as of May 4, 2026. Listed on the NSE stock exchange, this India-based company holds position #9729 globally and #456 in its home market, demonstrating a -0.99% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Healthcare Global Enterprises Limited's stock price Rs572.55 by its total outstanding shares 141000100 (141.00 Million). Analyse how efficiently does Healthcare Global Enterprises Limited generate cash to see how efficiently the company converts income to cash.
Healthcare Global Enterprises Limited Market Cap History: 2016 to 2026
Healthcare Global Enterprises Limited's market capitalization history from 2016 to 2026. Data shows growth from $377.40 Million to $873.06 Million (12.72% CAGR).
Index Memberships
Healthcare Global Enterprises Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$143.76 Billion | 0.61% | #51 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.20 Trillion | 0.03% | #376 of 750 |
Weight: Healthcare Global Enterprises Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Healthcare Global Enterprises Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Healthcare Global Enterprises Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Healthcare Global Enterprises Limited's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.27x
Healthcare Global Enterprises Limited's market cap is 2.27 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $377.40 Million | $5.84 Billion | -$14.61 Million | 0.06x | N/A |
| 2017 | $426.66 Million | $7.00 Billion | $221.73 Million | 0.06x | 1.92x |
| 2018 | $298.19 Million | $8.31 Billion | $205.23 Million | 0.04x | 1.45x |
| 2019 | $159.20 Million | $9.79 Billion | -$247.97 Million | 0.02x | N/A |
| 2020 | $248.17 Million | $10.96 Billion | -$1.07 Billion | 0.02x | N/A |
| 2021 | $364.14 Million | $10.13 Billion | -$1.93 Billion | 0.04x | N/A |
| 2022 | $438.32 Million | $13.98 Billion | $537.33 Million | 0.03x | 0.82x |
| 2023 | $557.34 Million | $16.94 Billion | $293.49 Million | 0.03x | 1.90x |
| 2024 | $745.89 Million | $19.12 Billion | $481.55 Million | 0.04x | 1.55x |
| 2025 | $1.01 Billion | $22.23 Billion | $444.10 Million | 0.05x | 2.27x |
Competitor Companies of HCG by Market Capitalization
Companies near Healthcare Global Enterprises Limited in the global market cap rankings as of May 4, 2026.
Key companies related to Healthcare Global Enterprises Limited by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #256 globally with a market cap of $96.85 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #962 globally with a market cap of $27.16 Billion USD ( €23.23 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #972 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1292 globally with a market cap of $19.57 Billion USD ( RM77.93 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #256 | HCA Holdings Inc | NYSE:HCA | $96.85 Billion | $433.09 |
| #962 | Fresenius SE & Co. KGaA | XETRA:FRE | $27.16 Billion | €41.25 |
| #972 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1292 | IHH Healthcare Bhd | KLSE:5225 | $19.57 Billion | RM8.82 |
Healthcare Global Enterprises Limited Historical Marketcap From 2016 to 2026
Between 2016 and today, Healthcare Global Enterprises Limited's market cap moved from $377.40 Million to $ 873.06 Million, with a yearly change of 12.72%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs873.06 Million | -13.51% |
| 2025 | Rs1.01 Billion | +35.34% |
| 2024 | Rs745.89 Million | +33.83% |
| 2023 | Rs557.34 Million | +27.15% |
| 2022 | Rs438.32 Million | +20.37% |
| 2021 | Rs364.14 Million | +46.73% |
| 2020 | Rs248.17 Million | +55.89% |
| 2019 | Rs159.20 Million | -46.61% |
| 2018 | Rs298.19 Million | -30.11% |
| 2017 | Rs426.66 Million | +13.05% |
| 2016 | Rs377.40 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of Healthcare Global Enterprises Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $873.06 Million USD |
| MoneyControl | $873.06 Million USD |
| MarketWatch | $873.06 Million USD |
| marketcap.company | $873.06 Million USD |
| Reuters | $873.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more